Clinical Trials in Dallas

Showing 3261-3280 of 15,003 trials

PLAN Intervention to Enhance Engagement of Latino Cancer Patients in Advanced Care Planning

NCT04889144

This trial tests whether Planning for Your Advance Care Needs (PLAN) intervention works to enhance Latino patients' understanding of and engagement in advanced care planning. The PLAN intervention may be an effective method to help people with cancer plan for and talk about advance care planning (the care they would want if they were unable to communicate) with their loved ones and doctors.

Locally Advanced Malignant Solid NeoplasmMetastatic Malignant Solid Neoplasm

Fred Hutchinson Cancer Center27 participantsStarted Jan 2021

New York, New York, United States • Dallas, Texas, United States • Seattle, Washington, United States +1 more locations

RECRUITINGPhase 2< 1 mile

Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers

NCT05919108

This phase II trial tests how well neratinib prior to the primary treatment (neoadjuvant) works in treating patients with stage I-III HER2 mutated lobular breast cancers. Neratinib is in a class of medications called kinase inhibitors. It works by blocking the action of an abnormal protein that signals cancer cells to multiply. This helps slow or stop the spread of cancer cells. Giving neratinib in addition to normal therapy may work better in treating cancer than the endocrine therapy patients would normally receive.

Anatomic Stage I Breast CancerAnatomic Stage II Breast CancerAnatomic Stage III Breast Cancer+1 more

Vanderbilt-Ingram Cancer Center30 participantsStarted May 2024

Atlanta, Georgia, United States • Pittsburgh, Pennsylvania, United States • Nashville, Tennessee, United States +2 more locations

PLAN Intervention to Enhance Engagement of Latino Cancer Patients in Advanced Care Planning

Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers

Find Trials by Condition in Dallas

A Study of Nemtabrutinib (MK-1026) in Participants With Relapsed or Refractory Hematologic Malignancies (ARQ 531-101/MK-1026-001)

Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma

A Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination Therapy

A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Eosinophilic Asthma

A Study of Danicopan in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Phase 2b Study of ALTO-100 in MDD

Gla-300 and IDeg-100 in Insulin-Naïve People With Type 2 Diabetes Mellitus and Renal Impairment

Study of an Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and Toddlers

Additional Support Program Via Text Messaging and Telephone-Based Counseling for Breast Cancer Patients Receiving Hormonal Therapy

CREST-2 Long-term Observational Extension Study

Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer

A Prospective, US-based Study Assessing Mogamulizumab-associated Rash in Patients Diagnosed With Mycosis Fungoides or Sezary Syndrome and Treated With Standard of Care Mogamulizumab

Maximal Use Study of Tapinarof Cream, 1% in Pediatric Subjects With Extensive Atopic Dermatitis

Velocity 2: An Anthrax Vaccine and Antibiotics Clinical Study

First-in-Human Study of OKI-219 in Advanced Solid Tumors and Advanced Breast Cancer

Cemiplimab and ISA101b Vaccine in Adult Participants With Recurrent/Metastatic Human Papillomavirus (HPV)16 Cervical Cancer Who Have Experienced Disease Progression After First Line Chemotherapy

Safety, Usability, and Effectiveness of a Gait Exoskeleton for Children and Adolescents With Neurodevelopmental Disorders.

Skin Reactions Related to Thoracic Implantable Chamber Dressings